与MS患者中残疾进展 (EDSS) 相关的因素
Anibal Arteaga-Noriega1,2, Jose Zapata-Berruecos3, Johanna Gutiérrez-Vargas4
1Grupo de Investigación en Epidemiología y Bioestadística, Universidad CES, Medellín, Colombia.
eNeurologicalSci
|January 19, 2026
概括
多发性硬化症 (MS) 的残疾进展不是线性的. 在MS患者中,初始小脑症状和性别是随着时间的推移导致残疾变化的重要预测因素.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床研究 临床研究
背景情况:
- 多发性硬化症 (MS) 是一种慢性,炎症性,自身免疫性疾病,影响中枢神经系统.
- 神经性残疾累积显著影响患者的生活质量.
- 扩展残疾状况尺度 (EDSS) 量化了MS相关的残疾.
研究的目的:
- 分析多发性硬化症患者随时间推移的残疾轨迹.
- 确定与每年残疾变化率相关的因素.
主要方法:
- 一个单一中心的研究使用医疗记录从2013-2021.
- 临床和人口特征的描述性统计数据.
- 一个多项式模型来评估随时间推移EDSS进展的变化.
主要成果:
- 用EDSS测量的残疾进展是非线性的,有更快和更慢的恶化时期.
- 双变量分析表明步态药物和肉毒素具有高β值.
- 多变量分析确定初始小脑症状和性别具有影响残疾进展的最高显著β值.
结论:
- 这项研究有助于在风险框架内预测MS的自然史.
- 预后模型对于指导慢性疾病的管理和患者咨询至关重要.
- 模型可以纳入各种结果,包括治疗反应和残疾变化.
相关概念视频
08:11Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
11.5K
An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.
11.5K
11:35The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
58.6K
Precise measurement of neurological and neuropsychological impairment and disability in multiple sclerosis is challenging. We report methodologic details on a new test, the Multiple Sclerosis Performance Test (MSPT). This new approach to the objective of quantification of MS related disability provides a computer-based platform for precise, valid measurement of MS...
58.6K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
306
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
306
Intellectual Disability
653
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
653
Learning Disabilities
578
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
578
14:43Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
8.5K
This work presents a protocol to administrate Spanish Curriculum-Based Measures for the early detection of reading, math, and writing difficulties. These tools could help practitioners and applied researchers working in the context of the Response to Intervention...
8.5K

